Anti-HERV-W Envelope Protein Antibody for Psychotic Diseases, Geneuro SA
Summary
The European Patent Office published application EP4157871A1, filed by Geneuro SA and Fondamental, covering an anti-HERV-W envelope protein antibody for use in treating psychotic diseases. Inventors are Marion Leboyer and Hervé Perron. The application, classified under IPC C07K 16/28 (antibodies) and A61P 25/18 (CNS disorders/pscychotic diseases), designates all European Patent Convention member states. This is a routine patent application publication by the EPO Patent Bulletin.
“ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES”
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.
What changed
The EPO Patent Bulletin published patent application EP4157871A1 for Geneuro SA, covering an anti-HERV-W envelope protein antibody composition for treating psychotic diseases. The application designates all EPC contracting states and is classified under C07K 16/28 (antibodies), A61P 25/18 (CNS disorders), and A61K 39/00 (immunological preparations).
Pharmaceutical and biotechnology companies developing CNS therapeutics, particularly those targeting retroviral envelope proteins or neuroinflammatory pathways, should review this application for competitive landscape awareness. The patent, if granted, could present freedom-to-operate considerations for similar therapeutic antibody development programs.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES
Publication EP4157871A1 Kind: A1 Apr 15, 2026
Applicants
Geneuro SA, Fondamental
Inventors
LEBOYER, Marion, PERRON, Hervé
IPC Classifications
C07K 16/28 20060101AFI20211203BHEP A61P 25/18 20060101ALI20211203BHEP A61K 39/00 20060101ALI20211203BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.